• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIU Xiaohan, TAN Yunying, LI Qiang, CHEN Xu, FU Junjie, YIN Jian. Synthesis and antitumor activity evaluation of glycoconjugates derived from natural product harmine[J]. Journal of China Pharmaceutical University, 2023, 54(6): 729-742. DOI: 10.11665/j.issn.1000-5048.2023041101
Citation: LIU Xiaohan, TAN Yunying, LI Qiang, CHEN Xu, FU Junjie, YIN Jian. Synthesis and antitumor activity evaluation of glycoconjugates derived from natural product harmine[J]. Journal of China Pharmaceutical University, 2023, 54(6): 729-742. DOI: 10.11665/j.issn.1000-5048.2023041101

Synthesis and antitumor activity evaluation of glycoconjugates derived from natural product harmine

Funds: This study was supported by the Open Project of Key Laboratory of Carbohydrate Chemistry and Biotechnology (Ministry of Education), Jiangnan University (No.KLCCB-KF202003)
More Information
  • Received Date: April 10, 2023
  • Revised Date: December 11, 2023
  • Based on our previous work, the study herein designed and synthesized eight glycoconjugates of natural product harmine (14a-14h)by introducing a cyclohexylmethyloxyl group at its C7 position and coupling a methyl-2-amino-β-D-glucopyranoside to the N9 position through different lengths of alkyl chains.In vitro anti-tumor activity screening and structure-activity relationship studies showed that the antitumor activity of the conjugates increased with the lengthening of the alkyl chain in the linker.Compound 14h exhibited significantly better proliferative inhibitory activity against MDA-MB-231 breast cancer cells than harmine.As compared to harmine, the introduction of the carbohydrate moiety improved the water solubility of compound 14h and enhanced its tumor cell selectivity through the Warburg effect.Mechanism of action studies revealed that compound 14h induced apoptosis and G0/G1 cell cycle arrest in MDA-MB-231 cells, and inhibited tumor cell migration by interfering with epithelial-mesenchymal transition process.This study provides a new approach for the development of antitumor drugs based on harmine.
  • [1]
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30.
    [2]
    Yang GX, Xiong J, Hu JF. 2017’s advanced natural products chemistry researches in China(1)[J]. J China Pharm Univ (中国药科大学学报), 2018, 49(5): 511-520.
    [3]
    Alam MM, Malebari AM, Syed N, et al. Design, synthesis and molecular docking studies of thymol based 1, 2, 3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells[J]. Bioorg Med Chem, 2021, 38: 116136.
    [4]
    Wang HB, He Y, Jian ML, et al. Breaking the bottleneck in anticancer drug development: efficient utilization of synthetic biology[J]. Molecules, 2022, 27(21): 7480.
    [5]
    Kumar K, Wang P, Wilson J, et al. Synthesis and biological validation of a harmine-based, central nervous system (CNS)-avoidant, selective, human β-cell regenerative dual-specificity tyrosine phosphorylation-regulated kinase A (DYRK1A) inhibitor[J]. J Med Chem, 2020, 63(6): 2986-3003.
    [6]
    Zhu YG, Lv YX, Guo CY, et al. Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway[J]. Life Sci, 2021, 270: 119112.
    [7]
    Zhang L, Li DC, Yu SL. Pharmacological effects of harmine and its derivatives: a review[J]. Arch Pharm Res, 2020, 43(12): 1259-1275.
    [8]
    Lakshmi Manasa K, Thatikonda S, Sigalapalli DK, et al. Design and synthesis of β-carboline linked aryl sulfonyl piperazine derivatives: DNA topoisomerase II inhibition with DNA binding and apoptosis inducing ability[J]. Bioorg Chem, 2020, 101: 103983.
    [9]
    Marconi GD, Fonticoli L, Rajan TS, et al. Epithelial-mesenchymal transition (EMT): the type-2 EMT in wound healing, tissue regeneration and organ fibrosis[J]. Cells, 2021, 10(7): 1587.
    [10]
    Zhao TM, Yang Y, Yang J, et al. Harmine-inspired design and synthesis of benzo[d]imidazo[2, 1-b]thiazole derivatives bearing 1, 3, 4-oxadiazole moiety as potential tumor suppressors[J]. Bioorg Med Chem, 2021, 46: 116367.
    [11]
    He JR, Chen SS, Yu T, et al. Harmine suppresses breast cancer cell migration and invasion by regulating TAZ-mediated epithelial-mesenchymal transition[J]. Am J Cancer Res, 2022, 12(6): 2612-2626.
    [12]
    Nafie E, Lolarga J, Lam B, et al. Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1[J]. PLoS One, 2021, 16(2): e0247652.
    [13]
    Lu DH, Qu LL, Wang C, et al. Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy[J]. Bioorg Chem, 2022, 120: 105604.
    [14]
    Du HT, Tian S, Chen JC, et al. Synthesis and biological evaluation of N9-substituted harmine derivatives as potential anticancer agents[J]. Bioorg Med Chem Lett, 2016, 26(16): 4015-4019.
    [15]
    Tang L. Design, synthesis and antitumor activity in vitro of derivatives of harmine N9-cinnamic acid(去氢骆驼蓬碱N9位-肉桂酸衍生物的设计、合成与体外抗肿瘤活性研究)[D]. Lanzhou: Lanzhou University, 2020.
    [16]
    Filali I, Bouajila J, Znati M, et al. Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities[J]. J Enzyme Inhib Med Chem, 2015, 30(3): 371-376.
    [17]
    Frédérick R, Bruyère C, Vancraeynest C, et al. Novel trisubstituted harmine derivatives with original in vitro anticancer activity[J]. J Med Chem, 2012, 55(14): 6489-6501.
    [18]
    Fu JJ, Yang JX, Seeberger PH, et al. Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment[J]. Carbohydr Res, 2020, 498: 108195.
    [19]
    Zhang XR, Ruan Q, Jiang YH, et al. Evaluation of 99mTc-CN5DG as a broad-spectrum SPECT probe for tumor imaging[J]. Transl Oncol, 2021, 14(1): 100966.
    [20]
    Wang HF, Yang XD, Zhao CL, et al. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation[J]. Bioorg Med Chem, 2019, 27(8): 1639-1645.
    [21]
    Chen F, Huang GL. Application of glycosylation in targeted drug delivery[J]. Eur J Med Chem, 2019, 182: 111612.
    [22]
    Cao J, Cui SS, Li SW, et al. Targeted cancer therapy with a 2-deoxyglucose-based adriamycin complex[J]. Cancer Res, 2013, 73(4): 1362-1373.
    [23]
    Punganuru SR, Mostofa AGM, Madala HR, et al. Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid[J]. Bioorg Med Chem Lett, 2016, 26(12): 2829-2833.
    [24]
    Wang SQ, Chen YT, Xia C, et al. Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion[J]. Bioorg Med Chem, 2022, 73: 117008.
    [25]
    He QL, Minn I, Wang QL, et al. Targeted delivery and sustained antitumor activity of triptolide through glucose conjugation[J]. Angew Chem Int Ed, 2016, 55(39): 12035-12039.
    [26]
    Henderson AS, Medina S, Bower JF, et al. Nucleophilic aromatic substitution (SNAr) as an approach to challenging carbohydrate-aryl ethers[J]. Org Lett, 2015, 17(19): 4846-4849.
  • Related Articles

    [1]SUN Dongyu, GONG Jingxu, LI Xuwen, HAN Guanying, GUO Yuewei. Studies on methyl xestopongoate analogues:design, synthesis and antitumor activities[J]. Journal of China Pharmaceutical University, 2018, 49(4): 413-421. DOI: 10.11665/j.issn.1000-5048.20180405
    [2]LI Mingtao, XU Dan, XUE Wenjun, YOU Qidong, SUN Liping. Design, synthesis and antitumor activities of oxazolo[5, 4-d]pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 425-431. DOI: 10.11665/j.issn.1000-5048.20170406
    [3]QIAO Yixue, MOU Yi, HUANG Zhangjian, AI Yong, KANG Fenghua, LAI Yisheng, ZHANG Yihua. Synthesis and antitumor activities of novel CDDO-Me analogues[J]. Journal of China Pharmaceutical University, 2015, 46(3): 289-293. DOI: 10.11665/j.issn.1000-5048.20150305
    [4]MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204
    [5]GU Xiaoke, TANG Xiaobo, HUANG Zhangjian, PENG Hui, ZHANG Yihua. Synthesis and antitumor activity of NO-releasing alkoxylbiphenyl derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(6): 657-661. DOI: 10.11665/j.issn.1000-5048.20140606
    [6]HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105
    [7]LIU Dexiu, PAN Huaying, SHI Hui, HUANG Xiaoying, LOU Hongxiang. Synthesis and antitumor activity of a novel bisbibenzyl derivative[J]. Journal of China Pharmaceutical University, 2013, 44(6): 515-519. DOI: 10.11665/j.issn.1000-5048.20130605
    [8]HU Kun, XU Hua-jin, XIN Wen-qun, CHEN Xin, REN Jie. Synthesis and antitumor activity of nitrogen mustard derivatives of formononetin[J]. Journal of China Pharmaceutical University, 2012, 43(2): 113-119.
    [9]ZHA Xiao-ming, ZHANG Fei-ran, SHAN Jia-qi, CHEN Yan-ke, ZHANG Yi-hua, LIU Jun, SUN Hong-bin. Synthesis and in vitro antitumor activities of novel soladulcidine derivatives[J]. Journal of China Pharmaceutical University, 2010, 41(6): 493-498.
    [10]ZHOU Mei, MA Lin, HAO Xiao-jiang, YANG Xiao-sheng. Antitumor activities of chemical constituents of Cephalotaxus fortunei in Guizhou province[J]. Journal of China Pharmaceutical University, 2009, 40(3): 209-212.

Catalog

    Article views (193) PDF downloads (257) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return